Our study indicates that variant genotypes of investigated MCM7 SNPs are not associated with the risk of AML, clinical features of AML patients, prognosis, or with FLT3, NPM1, and DNMT3A mutations. This evidence concerns the gene FLT3 and acute myeloid leukemia.